RecruitingNot Applicable

VIA Disc NP Registry 3.0

United States500 participantsStarted 2024-02-27

Plain-language summary

Registry is to observe and trend patterns of care and outcomes for patients treated with VIA Disc NP.

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Willing to sign the informed consent and deemed capable of complying with the requirements of the study protocol
✓. 18 years of age or older
✓. Literate, able to speak and read English, and able to complete questionnaires independently
✓. Subject received a VIA Disc NP injection with 1 or more levels within 90 days of the baseline visit.

✕. Participant did not receive VIA Disc NP injection
✕. Participant is pregnant (self-reported, no special study pregnancy testing needed).
✕. Any contraindications as noted in the VIA Disc NP Instructions for Use
✕. Previous treatment with VIA Disc NP

Numeric Pain Rating Scale (NPRS)

Timeframe: 1, 3, 6, & 12 months

Oswestry Disability Index (ODI)

Timeframe: 1, 3, 6, & 12 months

Patient Satisfaction

Timeframe: 1, 3, 6, & 12 months

Frequency of Pain Medication Use

Timeframe: 1, 3, 6, & 12 months

NCT IDNCT06345690

SponsorVIVEX Biologics, Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2027-01-01

Leslie Zaccari